5JKR image
Deposition Date 2016-04-26
Release Date 2016-09-14
Last Version Date 2024-01-10
Entry Detail
PDB ID:
5JKR
Title:
vaccinia virus D4/A20(1-50)w43a mutant
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Uracil-DNA glycosylase
Gene (Uniprot):OPG116
Chain IDs:A (auth: B), C (auth: A)
Chain Length:232
Number of Molecules:2
Biological Source:Vaccinia virus Copenhagen
Polymer Type:polypeptide(L)
Molecule:DNA polymerase processivity factor component A20
Gene (Uniprot):OPG148
Mutations:W43A
Chain IDs:B (auth: D), D (auth: C)
Chain Length:52
Number of Molecules:2
Biological Source:Vaccinia virus Copenhagen
Ligand Molecules
Primary Citation
Structural analysis of point mutations at the Vaccinia virus A20/D4 interface.
Acta Crystallogr.,Sect.F 72 687 691 (2016)
PMID: 27599859 DOI: 10.1107/S2053230X16011778

Abstact

The Vaccinia virus polymerase holoenzyme is composed of three subunits: E9, the catalytic DNA polymerase subunit; D4, a uracil-DNA glycosylase; and A20, a protein with no known enzymatic activity. The D4/A20 heterodimer is the DNA polymerase cofactor, the function of which is essential for processive DNA synthesis. The recent crystal structure of D4 bound to the first 50 amino acids of A20 (D4/A201-50) revealed the importance of three residues, forming a cation-π interaction at the dimerization interface, for complex formation. These are Arg167 and Pro173 of D4 and Trp43 of A20. Here, the crystal structures of the three mutants D4-R167A/A201-50, D4-P173G/A201-50 and D4/A201-50-W43A are presented. The D4/A20 interface of the three structures has been analysed for atomic solvation parameters and cation-π interactions. This study confirms previous biochemical data and also points out the importance for stability of the restrained conformational space of Pro173. Moreover, these new structures will be useful for the design and rational improvement of known molecules targeting the D4/A20 interface.

Legend

Protein

Chemical

Disease

Primary Citation of related structures